ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,955Medicare Part D Prescriptions Filled, Including Refills

Rank: 532 out of 5176

$493K Total Retail Price of All Prescriptions

Rank: 1211 out of 5176

227 Patients Receiving at Least One Drug in Part D
100%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 227 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 227 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 10,901 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 486 486 1 8
JANTOVEN 395 390 2 106
OMEPRAZOLE 393 393 3 3
METOPROLOL TARTRATE 349 349 4 6
MIRTAZAPINE 348 348 5 45
LEVOTHYROXINE SODIUM 336 336 6 4
LIDOCAINE HCL 326 326 10 7 325
POLYETHYLENE GLYCOL 3350 316 316 8 74
NYSTOP 275 274 9 283
DONEPEZIL HCL 267 267 10 28
AMLODIPINE BESYLATE 247 247 11 2
NAMENDA 246 246 12 47
LISINOPRIL 244 241 13 5
HYDROCODONE-ACETAMINOPHEN 239 238 S3 14 27
SSD 225 225 15 216
POTASSIUM CHLORIDE 210 210 16 34
DIVALPROEX SODIUM 200 200 17 104
CITALOPRAM HBR 173 173 18 31
SERTRALINE HCL 140 140 19 30
FAMOTIDINE 127 127 20 58
TRAZODONE HCL 125 125 21 71
IPRATROPIUM-ALBUTEROL 118 118 22 138
METOPROLOL SUCCINATE 117 117 23 11
QUETIAPINE FUMARATE 115 115 24 75
CEFPODOXIME PROXETIL 115 115 10 24 399
RISPERIDONE 114 114 26 78
NITROGLYCERIN PATCH 113 113 27 149
THERMAZENE 110 110 10 28 376
DIGOXIN 102 102 29 56
CARBIDOPA-LEVODOPA 96 96 30 98
CLOPIDOGREL 96 96 30 26
ISOSORBIDE MONONITRATE ER 89 89 32 44
RANITIDINE HCL 82 82 33 36
SILVER SULFADIAZINE 82 82 33 207
SANTYL 81 81 35 124
SIMVASTATIN 79 79 36 1
LANTUS 74 74 37 66
TAMSULOSIN HCL 67 67 38 20
HUMULIN R 67 67 38 347
NOVOLIN N 65 65 40 304
DILTIAZEM HCL 65 65 40 316
PLAVIX 60 60 42 29
PANTOPRAZOLE SODIUM 60 55 42 61
HYDROCHLOROTHIAZIDE 57 57 44 10
CLONIDINE HCL 56 55 45 79
FLUOCINONIDE 56 56 45 165
PAROXETINE HCL 55 55 47 93
ATENOLOL 54 54 48 12
CEPHALEXIN 54 54 48 189
ESCITALOPRAM OXALATE 53 46 50 89
TIMOLOL MALEATE 52 52 51 318
CYMBALTA 52 52 51 90
NOVOLOG 52 52 51 168
WARFARIN SODIUM 51 47 54 13
PREDNISONE 50 50 55 52
CEFTRIAXONE 50 50 55 338
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.